Anti-obesity and anti-diabetic effects of nitrate and nitrite

Nitric Oxide - Biology and Chemistry

Volumn 70, Issue , 2017, Pages 9-24

  Ghasemi, Asghar ^a   Jeddi, Sajad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Insulin; Nitrate; Nitric oxide; Nitrite; Obesity; Type 2 diabetes

Indexed keywords

CAVEOLIN 1; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR; INSULIN RECEPTOR ALPHA; INSULIN RECEPTOR BETA; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SH2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; ANTIOXIDANT; NITRIC ACID DERIVATIVE;

AGING; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOBESITY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; DRUG ACTIVITY; DRUG EFFICACY; EC50; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE TOLERANCE; GLYCATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NEGATIVE FEEDBACK; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; ANIMAL; BIOSYNTHESIS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTI-OBESITY AGENTS; ANTIOXIDANTS; HUMANS; HYPOGLYCEMIC AGENTS; NITRATES; NITRIC OXIDE; NITRITES;

EID: 85027397752     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2017.08.003     Document Type: Review

References (221)

1. Hruby, A., Hu, F.B., The epidemiology of obesity: a big picture. Pharmacoeconomics 33 (2015), 673–689.
2. Trayhurn, P., Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93 (2013), 1–21.
3. Wu, L., Shen, C., Seed Ahmed, M., Ostenson, C.G., Gu, H.F., Adenylate cyclase 3: a new target for anti-obesity drug development. Obes. Rev. 17 (2016), 907–914.
4. Sansbury, B.E., Hill, B.G., Regulation of obesity and insulin resistance by nitric oxide. Free Radic. Biol. Med. 73 (2014), 383–399.
5. Chen, A.Y., Kim, S.E., Houtrow, A.J., Newacheck, P.W., Prevalence of obesity among children with chronic conditions. Obes. (Silver Spring) 18 (2010), 210–213.
6. Valente, A., Jamurtas, A.Z., Koutedakis, Y., Flouris, A.D., Molecular pathways linking non-shivering thermogenesis and obesity: focusing on brown adipose tissue development. Biol. Rev. Camb. Philos. Soc. 90 (2015), 77–88.
7. Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
8. Carter, P., Gray, L.J., Troughton, J., Khunti, K., Davies, M.J., Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. Br. Med. J., 341, 2010, c4229.
9. Chen, L., Magliano, D.J., Zimmet, P.Z., The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat. Rev. Endocrinol. 8 (2012), 228–236.
10. Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87 (2010), 4–14.
11. Jeddi, S., Syedmoradi, L., Bagheripour, F., Ghasemi, A., The effects of vitamin D on insulin release from isolated islets of rats. Int. J. Endocrinol. Metab., 13, 2015, e20620.
12. Murad, F., Shattuck Lecture, Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med. 355 (2006), 2003–2011.
13. Jiang, H., Torregrossa, A.C., Potts, A., Pierini, D., Aranke, M., Garg, H.K., Bryan, N.S., Dietary nitrite improves insulin signaling through GLUT4 translocation. Free Radic. Biol. Med. 67 (2014), 51–57.
14. Joost, H.G., Tschop, M.H., NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity?. Endocrinology 148 (2007), 4545–4547.
15. Ghasemi, A., Zahediasl, S., Azizi, F., Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur. J. Epidemiol. 25 (2010), 45–53.
16. Roberts, L.D., Ashmore, T., Kotwica, A.O., Murfitt, S.A., Fernandez, B.O., Feelisch, M., Murray, A.J., Griffin, J.L., Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway. Diabetes 64 (2015), 471–484.
17. McNally, B., Griffin, J.L., Roberts, L.D., Dietary inorganic nitrate: from villain to hero in metabolic disease?. Mol. Nutr. Food Res. 60 (2016), 67–78.
18. Anderssohn, M., Schwedhelm, E., Luneburg, N., Vasan, R.S., Boger, R.H., Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diabetes & Vasc. Dis. Res. 7 (2010), 105–118.
19. Ohtake, K., Nakano, G., Ehara, N., Sonoda, K., Ito, J., Uchida, H., Kobayashi, J., Dietary nitrite supplementation improves insulin resistance in type 2 diabetic KKA(y) mice. Nitric Oxide 44 (2015), 31–38.
20. Kobayashi, J., Nitric oxide and insulin resistance. Immunoendocrinology, 2, 2015, e657.
21. Carlstrom, M., Larsen, F.J., Nystrom, T., Hezel, M., Borniquel, S., Weitzberg, E., Lundberg, J.O., Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 17716–17720.
22. Peleli, M., Hezel, M., Zollbrecht, C., Persson, A.E., Lundberg, J.O., Weitzberg, E., Fredholm, B.B., Carlstrom, M., In adenosine A2B knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver. Front. Physiol., 6, 2015, 222.
23. Blekkenhorst, L.C., Bondonno, C.P., Lewis, J.R., Devine, A., Woodman, R.J., Croft, K.D., Lim, W.H., Wong, G., Beilin, L.J., Prince, R.L., Hodgson, J.M., Association of dietary nitrate with atherosclerotic vascular disease mortality: a prospective cohort study of older adult women. Am. J. Clin. Nutr. 106 (2017), 207–216.
24. Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., Scherrer, U., Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104 (2001), 342–345.
25. Roberts, L.D., Does inorganic nitrate say NO to obesity by browning white adipose tissue?. Adipocyte 4 (2015), 311–314.
26. Roberts, L.D., Ashmore, T., McNally, B.D., Murfitt, S.A., Fernandez, B.O., Feelisch, M., Lindsay, R., Siervo, M., Williams, E.A., Murray, A.J., Griffin, J.L., Inorganic nitrate mimics exercise-stimulated muscular fiber-type switching and myokine and gamma-aminobutyric acid release. Diabetes 66 (2017), 674–688.
27. Ghasemi, A., Zahediasl, S., Potential therapeutic effects of nitrate/nitrite and type 2 diabetes mellitus. Int. J. Endocrinol. Metabol. 11 (2013), 63–64.
28. Bahadoran, Z., Ghasemi, A., Mirmiran, P., Azizi, F., Hadaegh, F., Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications. Nutr. Metab. (Lond.), 12, 2015, 16.
29. Jeddi, S., Khalifi, S., Ghanbari, M., Bageripour, F., Ghasemi, A., Effects of nitrate intake on myocardial ischemia-reperfusion injury in diabetic rats. Arq. Bras. Cardiol. 107 (2016), 339–347.
30. Kina-Tanada, M., Sakanashi, M., Tanimoto, A., Kaname, T., Matsuzaki, T., Noguchi, K., Uchida, T., Nakasone, J., Kozuka, C., Ishida, M., Kubota, H., Taira, Y., Totsuka, Y., Kina, S.I., Sunakawa, H., Omura, J., Satoh, K., Shimokawa, H., Yanagihara, N., Maeda, S., Ohya, Y., Matsushita, M., Masuzaki, H., Arasaki, A., Tsutsui, M., Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice. Diabetologia 60 (2017), 1138–1151.
31. Higashino, H., Tabuchi, M., Yamagata, S., Kurita, T., Miya, H., Mukai, H., Miya, Y., Serum nitric oxide metabolite levels in groups of patients with various diseases in comparison of healthy control subjects. J. Med. Sci. 10 (2010), 1–11.
32. Ghasemi, A., Zahedi Asl, S., Is nitric oxide a hormone?. Iran. Biomed. J. 15 (2011), 59–65.
33. Luiking, Y.C., Ten Have, G.A., Wolfe, R.R., Deutz, N.E., Arginine de novo and nitric oxide production in disease states. Am. J. Physiol. Endocrinol. Metabol. 303 (2012), E1177–E1189.
34. Tan, B., Li, X., Yin, Y., Wu, Z., Liu, C., Tekwe, C.D., Wu, G., Regulatory roles for L-arginine in reducing white adipose tissue. Front. Biosci. Landmark Ed. 17 (2012), 2237–2246.
35. Knowles, R.G., Moncada, S., Nitric oxide synthases in mammals. Biochem. J. 298:Pt 2 (1994), 249–258.
36. Cannon, R.O.r., Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin. Chem. 44 (1998), 1809–1819.
37. Yoon, Y., Song, J., Hong, S.H., Kim, J.Q., Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46 (2000), 1626–1630.
38. Wu, G., Meininger, C.J., Regulation of nitric oxide synthesis by dietary factors. Annu. Rev. Nutr. 22 (2002), 61–86.
39. Dudzinski, D.M., Igarashi, J., Greif, D., Michel, T., The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 46 (2006), 235–276.
40. Pacher, P., Beckman, J.S., Liaudet, L., Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007), 315–424.
41. Wang, X.L., Sim, A.S., Badenhop, R.F., McCredie, R.M., Wilcken, D.E., A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2 (1996), 41–45.
42. Luiking, Y.C., Engelen, M.P., Deutz, N.E., Regulation of nitric oxide production in health and disease. Curr. Opin. Clin. Nutr. Metabol. Care 13 (2010), 97–104.
43. Jung, K.H., Chu, K., Ko, S.Y., Lee, S.T., Sinn, D.I., Park, D.K., Kim, J.M., Song, E.C., Kim, M., Roh, J.K., Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 37 (2006), 2744–2750.
44. Schwartz, D., Mendonca, M., Schwartz, I., Xia, Y., Satriano, J., Wilson, C.B., Blantz, R.C., Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 100 (1997), 439–448.
45. Buga, G.M., Griscavage, J.M., Rogers, N.E., Ignarro, L.J., Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73 (1993), 808–812.
46. Abu-Soud, H.M., Ichimori, K., Nakazawa, H., Stuehr, D.J., Regulation of inducible nitric oxide synthase by self-generated NO. Biochemistry 40 (2001), 6876–6881.
47. Caldwell, R.B., Toque, H.A., Narayanan, S.P., Caldwell, R.W., Arginase: an old enzyme with new tricks. Trends Pharmacol. Sci. 36 (2015), 395–405.
48. Mueller, C.F., Laude, K., McNally, J.S., Harrison, D.G., ATVB in focus: redox mechanisms in blood vessels. Arterioscler., Thromb., Vasc. Biol. 25 (2005), 274–278.
49. Forstermann, U., Sessa, W.C., Nitric oxide synthases: regulation and function. Eur. Heart J. 33 (2012), 829–837.
50. Wu, G., Meininger, C.J., Nitric oxide and vascular insulin resistance. Biofactors 35 (2009), 21–27.
51. Lundberg, J.O., Weitzberg, E., Biology of nitrogen oxides in the gastrointestinal tract. Gut 62 (2013), 616–629.
52. Lee, J., Ryu, H., Ferrante, R.J., Morris, S.M. Jr., Ratan, R.R., Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 4843–4848.
53. Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C., Smith, L., Golden, M., McKenzie, H., Stomach NO synthesis. Nature, 368, 1994, 502.
54. Lundberg, J.O., Weitzberg, E., Lundberg, J.M., Alving, K., Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35 (1994), 1543–1546.
55. Lundberg, J.O., Weitzberg, E., The biological role of nitrate and nitrite: the times they are a-changin'. Nitric Oxide 22 (2010), 61–63.
56. Parthasarathy, D.K., Bryan, N.S., Sodium nitrite: the “cure” for nitric oxide insufficiency. Meat Sci. 92 (2012), 274–279.
57. Lundberg, J.O., Weitzberg, E., Gladwin, M.T., The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7 (2008), 156–167.
58. Lundberg, J.O., Weitzberg, E., NO-synthase independent NO generation in mammals. Biochem. Biophys. Res. Commun. 396 (2010), 39–45.
59. Dauncey, S., Can dietary nitrate supplements improve tolerance to hypoxia?. J. Intensive Care Soc. 13 (2012), 198–204.
60. Jansson, E.A., Huang, L., Malkey, R., Govoni, M., Nihlen, C., Olsson, A., Stensdotter, M., Petersson, J., Holm, L., Weitzberg, E., Lundberg, J.O., A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat. Chem. Biol. 4 (2008), 411–417.
61. Nystrom, T., Ortsater, H., Huang, Z., Zhang, F., Larsen, F.J., Weitzberg, E., Lundberg, J.O., Sjoholm, A., Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion. Free Radic. Biol. Med. 53 (2012), 1017–1023.
62. Chow, C.K., Hong, C.B., Dietary vitamin E and selenium and toxicity of nitrite and nitrate. Toxicology 180 (2002), 195–207.
63. Crawford, N.M., Guo, F.Q., New insights into nitric oxide metabolism and regulatory functions. Trends Plant Sci. 10 (2005), 195–200.
64. Henquin, J.C., Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000), 1751–1760.
65. Novelli, M., Pocai, A., Lajoix, A.D., Beffy, P., Bezzi, D., Marchetti, P., Gross, R., Masiello, P., Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 219 (2004), 77–82.
66. Shimabukuro, M., Ohneda, M., Lee, Y., Unger, R.H., Role of nitric oxide in obesity-induced beta cell disease. J. Clin. Invest. 100 (1997), 290–295.
67. Lajoix, A.D., Reggio, H., Chardes, T., Peraldi-Roux, S., Tribillac, F., Roye, M., Dietz, S., Broca, C., Manteghetti, M., Ribes, G., Wollheim, C.B., Gross, R., A neuronal isoform of nitric oxide synthase expressed in pancreatic beta-cells controls insulin secretion. Diabetes 50 (2001), 1311–1323.
68. Broniowska, K.A., Oleson, B.J., Corbett, J.A., Beta-Cell responses to nitric oxide. Vitam. Hormones 95 (2014), 299–322.
69. Natali, A., Ribeiro, R., Baldi, S., Tulipani, A., Rossi, M., Venturi, E., Mari, A., Macedo, M.P., Ferrannini, E., Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia 56 (2013), 1183–1191.
70. Mosen, H., Ostenson, C.G., Lundquist, I., Alm, P., Henningsson, R., Jimenez-Feltstrom, J., Guenifi, A., Efendic, S., Salehi, A., Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production. Regul. Pept. 151 (2008), 139–146.
71. Kruszelnicka, O., Nitric oxide vs insulin secretion, action and clearance. Diabetologia 57 (2014), 257–258.
72. Krentz, A., Insulin Resistance: a Clinical Handbook. 2002, John Wiley & Sons.
73. Boucher, J., Kleinridders, A., Kahn, C.R., Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol., 6, 2014, a009191.
74. Saltiel, A.R., Pessin, J.E., Insulin signaling pathways in time and space. Trends Cell Biol. 12 (2002), 65–71.
75. Ishii, M., Shimizu, S., Nagai, T., Shiota, K., Kiuchi, Y., Yamamoto, T., Stimulation of tetrahydrobiopterin synthesis induced by insulin: possible involvement of phosphatidylinositol 3-kinase. Int. J. Biochem. Cell Biol. 33 (2001), 65–73.
76. Yu, Q., Gao, F., Ma, X.L., Insulin says NO to cardiovascular disease. Cardiovasc. Res. 89 (2011), 516–524.
77. Wu, G., Majumdar, S., Zhang, J., Lee, H., Meininger, C.J., Insulin stimulates glycolysis and pentose cycle activity in bovine microvascular endothelial cells. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108 (1994), 179–185.
78. Muniyappa, R., Lee, S., Chen, H., Quon, M.J., Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metabol. 294 (2008), E15–E26.
79. Rachek, L.I., Free fatty acids and skeletal muscle insulin resistance. Prog. Mol. Biol. Transl. Sci. 121 (2014), 267–292.
80. Borai, A., Livingstone, C., Kaddam, I., Ferns, G., Selection of the appropriate method for the assessment of insulin resistance. BMC Med. Res. Methodol., 11, 2011, 158.
81. Muniyappa, R., Chen, H., Muzumdar, R.H., Einstein, F.H., Yan, X., Yue, L.Q., Barzilai, N., Quon, M.J., Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats. Am. J. Physiol. Endocrinol. Metabol. 297 (2009), E1023–E1029.
82. Shankar, R.R., Wu, Y., Shen, H.Q., Zhu, J.S., Baron, A.D., Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49 (2000), 684–687.
83. Cordes, C.M., Bennett, R.G., Siford, G.L., Hamel, F.G., Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem. Pharmacol. 77 (2009), 1064–1073.
84. Tsuzuki, T., Shinozaki, S., Nakamoto, H., Kaneki, M., Goto, S., Shimokado, K., Kobayashi, H., Naito, H., Voluntary exercise can ameliorate insulin resistance by reducing iNOS-mediated S-Nitrosylation of Akt in the liver in obese rats. PLoS One, 10, 2015, e0132029.
85. L.M., V., Herrera, N.R.-O., Rat as a model system for hypertension drug discovery. Biochem. Insights 5 (2008), 179–184.
86. Mannick, J.B., Schonhoff, C.M., Nitrosylation: the next phosphorylation?. Arch. Biochem. Biophys. 408 (2002), 1–6.
87. Wiseman, D.A., Thurmond, D.C., The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act. Curr. Diabetes Rev. 8 (2012), 303–315.
88. Choi, K., Kim, Y.B., Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J. Intern Med. 25 (2010), 119–129.
89. Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B., de Oliveira, M.G., Velloso, L.A., Curi, R., Saad, M.J., S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54 (2005), 959–967.
90. Ovadia, H., Haim, Y., Nov, O., Almog, O., Kovsan, J., Bashan, N., Benhar, M., Rudich, A., Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity. J. Biol. Chem. 286 (2011), 30433–30443.
91. Yasukawa, T., Tokunaga, E., Ota, H., Sugita, H., Martyn, J.A., Kaneki, M., S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J. Biol. Chem. 280 (2005), 7511–7518.
92. de Luca, C., Olefsky, J.M., Inflammation and insulin resistance. FEBS Lett. 582 (2008), 97–105.
93. Trane, A.E., Pavlov, D., Sharma, A., Saqib, U., Lau, K., van Petegem, F., Minshall, R.D., Roman, L.J., Bernatchez, P.N., Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance. J. Biol. Chem. 289 (2014), 13273–13283.
94. Erzurum, S.C., Ghosh, S., Janocha, A.J., Xu, W., Bauer, S., Bryan, N.S., Tejero, J., Hemann, C., Hille, R., Stuehr, D.J., Feelisch, M., Beall, C.M., Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 17593–17598.
95. Rajapakse, N.W., Nanayakkara, S., Kaye, D.M., Pathogenesis and treatment of the cardiorenal syndrome: implications of L-arginine-nitric oxide pathway impairment. Pharmacol. Ther. 154 (2015), 1–12.
96. Tanrikulu-Kucuk, S., Kocak, H., Oner-Iyidogan, Y., Seyithanoglu, M., Topparmak, E., Kayan-Tapan, T., Serum fetuin-A and arginase-1 in human obesity model: is there any interaction between inflammatory status and arginine metabolism?. Scand. J. Clin. Lab. Invest. 75 (2015), 301–307.
97. Catalan, V., Gomez-Ambrosi, J., Rodriguez, A., Silva, C., Rotellar, F., Gil, M.J., Cienfuegos, J.A., Salvador, J., Fruhbeck, G., Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol. Oxf. 68 (2008), 213–219.
98. Michel, J.B., Feron, O., Sacks, D., Michel, T., Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J. Biol. Chem. 272 (1997), 15583–15586.
99. Muhammed, S.J., Lundquist, I., Salehi, A., Pancreatic beta-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes. Diabetes, Obes. Metabol. 14 (2012), 1010–1019.
100. Perreault, M., Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7 (2001), 1138–1143.
101. El Assar, M., Ruiz de Adana, J.C., Angulo, J., Pindado Martinez, M.L., Hernandez Matias, A., Rodriguez-Manas, L., Preserved endothelial function in human obesity in the absence of insulin resistance. J. Transl. Med., 11, 2013, 263.
102. Rudofsky, G., Roeder, E., Merle, T., Hildebrand, M., Nawroth, P.P., Wolfrum, C., Weight loss improves endothelial function independently of ADMA reduction in severe obesity. Horm. Metab. Res. 43 (2011), 343–348.
103. Lupattelli, G., De Vuono, S., Boni, M., Helou, R., Raffaele Mannarino, M., Rita Roscini, A., Alaeddin, A., Pirro, M., Vaudo, G., Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity. J. Atheroscler. Thromb. 20 (2013), 924–933.
104. Sansbury, B.E., Hill, B.G., Antiobesogenic role of endothelial nitric oxide synthase. Vitam. Horm. 96 (2014), 323–346.
105. Biasucci, L.M., Graziani, F., Rizzello, V., Liuzzo, G., Guidone, C., De Caterina, A.R., Brugaletta, S., Mingrone, G., Crea, F., Paradoxical preservation of vascular function in severe obesity. Am. J. Med. 123 (2010), 727–734.
106. Czernichow, S., Greenfield, J.R., Galan, P., Bastard, J.P., Charnaux, N., Samaras, K., Safar, M.E., Blacher, J., Hercberg, S., Levy, B.I., Microvascular dysfunction in healthy insulin-sensitive overweight individuals. J. Hypertens. 28 (2010), 325–332.
107. Gamboa, A., Okamoto, L.E., Arnold, A.C., Figueroa, R.A., Diedrich, A., Raj, S.R., Paranjape, S.Y., Farley, G., Abumrad, N., Biaggioni, I., Autonomic blockade improves insulin sensitivity in obese subjects. Hypertension 64 (2014), 867–874.
108. Bluher, M., The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr. Opin. Lipidol. 21 (2010), 38–43.
109. Bluher, M., Are there still healthy obese patients?. Curr. Opin. Endocrinol. Diabetes Obes. 19 (2012), 341–346.
110. Lee, J.M., Okumura, M.J., Davis, M.M., Herman, W.H., Gurney, J.G., Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 29 (2006), 2427–2432.
111. Yang, T., Peleli, M., Zollbrecht, C., Giulietti, A., Terrando, N., Lundberg, J.O., Weitzberg, E., Carlstrom, M., Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism. Free Radic. Biol. Med. 83 (2015), 159–166.
112. Bhattacharya, I., Dominguez, A.P., Dragert, K., Humar, R., Haas, E., Battegay, E.J., Hypoxia potentiates tumor necrosis factor-alpha induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in white and brown adipocytes. Biochem. Biophys. Res. Commun. 461 (2015), 287–292.
113. Evans, J.M., Omentectomy, visceral fat, and insulin resistance. Obes. (Silver Spring), 17, 2009, 1979.
114. Trayhurn, P., Adipocyte biology. Obes. Rev. 8:Suppl 1 (2007), 41–44.
115. Wells, J.C., The evolution of human fatness and susceptibility to obesity: an ethological approach. Biol. Rev. Camb. Philos. Soc. 81 (2006), 183–205.
116. Wu, C.L., Zhao, S.P., Yu, B.L., Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease. Biol. Rev. Camb. Philos. Soc. 90 (2015), 367–376.
117. Stephens, J.M., The fat controller: adipocyte development. PLoS Biol., 10, 2012, e1001436.
118. Rammos, C., Luedike, P., Hendgen-Cotta, U., Rassaf, T., Potential of dietary nitrate in angiogenesis. World J. Cardiol. 7 (2015), 652–657.
119. Klinger, J.R., The nitric oxide/cGMP signaling pathway in pulmonary hypertension. Clin. Chest Med. 28 (2007), 143–167.
120. Norouzirad, R., Gonzalez-Muniesa, P., Ghasemi, A., Hypoxia in obesity and diabetes: potential therapeutic effects of hyperoxia and nitrate. Oxid. Med. Cell Longev., 2017, 2017, 5350267.
121. Omar, S.A., Webb, A.J., Lundberg, J.O., Weitzberg, E., Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. J. Intern. Med. 279 (2016), 315–336.
122. Mukhopadhyay, S., Ghosh, D., Chatterjee, A., Sinha, S., Tripathy, S., Chandra, A.K., Evaluation of possible goitrogenic and anti-thyroidal effect of nitrate, a potential environmental pollutant. Indian J. Physiol. Pharmacol. 49 (2005), 284–288.
123. van Velzen, A.G., Sips, A.J., Schothorst, R.C., Lambers, A.C., Meulenbelt, J., The oral bioavailability of nitrate from nitrate-rich vegetables in humans. Toxicol. Lett. 181 (2008), 177–181.
124. Weitzberg, E., Lundberg, J.O., Nonenzymatic nitric oxide production in humans. Nitric Oxide 2 (1998), 1–7.
125. Bahadoran, Z., Mirmiran, P., Ghasemi, A., Kabir, A., Azizi, F., Hadaegh, F., Is dietary nitrate/nitrite exposure a risk factor for development of thyroid abnormality? A systematic review and meta-analysis. Nitric Oxide 47 (2015), 65–76.
126. Kevil, C.G., Kolluru, G.K., Pattillo, C.B., Giordano, T., Inorganic nitrite therapy: historical perspective and future directions. Free Radic. Biol. Med. 51 (2011), 576–593.
127. Bartholomew, B., Hill, M.J., The pharmacology of dietary nitrate and the origin of urinary nitrate. Food Chem. Toxicol. 22 (1984), 789–795.
128. Pannala, A.S., Mani, A.R., Spencer, J.P., Skinner, V., Bruckdorfer, K.R., Moore, K.P., Rice-Evans, C.A., The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic. Biol. Med. 34 (2003), 576–584.
129. Bryan, N.S., Grisham, M.B., Methods to detect nitric oxide and its metabolites in biological samples. Free Radic. Biol. Med. 43 (2007), 645–657.
130. Ghasemi, A., Zahediasl, S., Preanalytical and analytical considerations for measuring nitric oxide metabolites in serum or plasma using the Griess method. Clin. Lab. 58 (2012), 615–624.
131. Tatsch, E., Bochi, G.V., Pereira Rda, S., Kober, H., Agertt, V.A., de Campos, M.M., Gomes, P., Duarte, M.M., Moresco, R.N., A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin. Biochem. 44 (2011), 348–350.
132. Milsom, A.B., Jones, C.J., Goodfellow, J., Frenneaux, M.P., Peters, J.R., James, P.E., Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus. Diabetologia 45 (2002), 1515–1522.
133. O'Kane, P.D., Jackson, G., Ferro, A., Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine. Atherosclerosis 196 (2008), 574–579.
134. Kanbak, G., Akalin, A., Dokumacioglu, A., Ozcelik, E., Bal, C., Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: role of biomarkers. Diabetes & Metabol. Syndr. Clin. Res. Rev. 5 (2011), 7–11.
135. Zeballos, G.A., Bernstein, R.D., Thompson, C.I., Forfia, P.R., Seyedi, N., Shen, W., Kaminiski, P.M., Wolin, M.S., Hintze, T.H., Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91 (1995), 2982–2988.
136. Wennmalm, A., Benthin, G., Edlund, A., Jungersten, L., Kieler-Jensen, N., Lundin, S., Westfelt, U.N., Petersson, A.S., Waagstein, F., Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ. Res. 73 (1993), 1121–1127.
137. James, P.E., Willis, G.R., Allen, J.D., Winyard, P.G., Jones, A.M., Nitrate pharmacokinetics: taking note of the difference. Nitric Oxide 48 (2015), 44–50.
138. Romitelli, F., Santini, S.A., Chierici, E., Pitocco, D., Tavazzi, B., Amorini, A.M., Lazzarino, G., Di Stasio, E., Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. J. Chromatogr. B, Anal. Technol. Biomed. Life Sci. 851 (2007), 257–267.
139. Huynh, N.N., Chin-Dusting, J., Amino acids, arginase and nitric oxide in vascular health. Clin. Exp. Pharmacol. Physiol. 33 (2006), 1–8.
140. Siervo, M., Lara, J., Ogbonmwan, I., Mathers, J.C., Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J. Nutr. 143 (2013), 818–826.
141. Ashora, A.W., Larab, J., Siervo, M., Medium-termeffects of dietary nitrate supplementation on systolic and diastolic blood pressure in adults: a systematic review and meta-analysis. J. Hypertens. 35 (2017), 1353–1359.
142. Lundberg, J.O., Gladwin, M.T., Ahluwalia, A., Benjamin, N., Bryan, N.S., Butler, A., Cabrales, P., Fago, A., Feelisch, M., Ford, P.C., Freeman, B.A., Frenneaux, M., Friedman, J., Kelm, M., Kevil, C.G., Kim-Shapiro, D.B., Kozlov, A.V., Lancaster, J.R. Jr., Lefer, D.J., McColl, K., McCurry, K., Patel, R.P., Petersson, J., Rassaf, T., Reutov, V.P., Richter-Addo, G.B., Schechter, A., Shiva, S., Tsuchiya, K., van Faassen, E.E., Webb, A.J., Zuckerbraun, B.S., Zweier, J.L., Weitzberg, E., Nitrate and nitrite in biology, nutrition and therapeutics. Nat. Chem. Biol. 5 (2009), 865–869.
143. Greenway, F.L., Predmore, B.L., Flanagan, D.R., Giordano, T., Qiu, Y., Brandon, A., Lefer, D.J., Patel, R.P., Kevil, C.G., Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients. Diabetes Technol. Ther. 14 (2012), 552–560.
144. Khalifi, S., Rahimipour, A., Jeddi, S., Ghanbari, M., Kazerouni, F., Ghasemi, A., Dietary nitrate improves glucose tolerance and lipid profile in an animal model of hyperglycemia. Nitric Oxide 44 (2015), 24–30.
145. Lai, Y.-C., Tabima, D.M., Dube, J.J., Hughan, K.S., Vanderpool, R.R., Goncharov, D.A., Croix, C.M.S., Garcia-Ocaña, A., Goncharova, E.A., Tofovic, S.P., SIRT3–AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction. Circulation 133 (2016), 717–731.
146. Singamsetty, S., Watanabe, Y., Guo, L., Corey, C., Wang, Y., Tejero, J., McVerry, B.J., Gladwin, M.T., Shiva, S., O'Donnell, C.P., Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model of obesity and insulin resistance. J. Physiol. 593 (2015), 3135–3145.
147. Hezel, M.P., Liu, M., Schiffer, T.A., Larsen, F.J., Checa, A., Wheelock, C.E., Carlstrom, M., Lundberg, J.O., Weitzberg, E., Effects of long-term dietary nitrate supplementation in mice. Redox Biol. 5 (2015), 234–242.
148. Carlstrom, M., Liu, M., Yang, T., Zollbrecht, C., Huang, L., Peleli, M., Borniquel, S., Kishikawa, H., Hezel, M., Persson, A.E., Weitzberg, E., Lundberg, J.O., Cross-talk between nitrate-nitrite-NO and NO synthase pathways in control of vascular NO homeostasis. Antioxidants Redox Signal. 23 (2015), 295–306.
149. Ashmore, T., Roberts, L.D., Morash, A.J., Kotwica, A.O., Finnerty, J., West, J.A., Murfitt, S.A., Fernandez, B.O., Branco, C., Cowburn, A.S., Clarke, K., Johnson, R.S., Feelisch, M., Griffin, J.L., Murray, A.J., Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism. BMC Biol., 13, 2015, 110.
150. Essawy, S.S., Abdel-Sater, K.A., Elbaz, A.A., Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid. Archiv. Med. Sci. 10 (2014), 537–545.
151. El-Wakf, A.M., Hassan, H.A., Mahmoud, A.Z., Habza, M.N., Fenugreek potent activity against nitrate-induced diabetes in young and adult male rats. Cytotechnology 67 (2015), 437–447.
152. Gheibi, S., Bakhtiarzadeh, F., Jeddi, S., Farrokhfall, K., Zardooz, H., Ghasemi, A., Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats. Nitric Oxide 64 (2017), 39–51.
153. Gao, X., Yang, T., Liu, M., Peleli, M., Zollbrecht, C., Weitzberg, E., Lundberg, J.O., Persson, A.E., Carlstrom, M., NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite. Hypertension 65 (2015), 161–170.
154. Carlstrom, M., Persson, A.E., Larsson, E., Hezel, M., Scheffer, P.G., Teerlink, T., Weitzberg, E., Lundberg, J.O., Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. Cardiovasc Res. 89 (2011), 574–585.
155. Montenegro, M.F., Amaral, J.H., Pinheiro, L.C., Sakamoto, E.K., Ferreira, G.C., Reis, R.I., Marcal, D.M., Pereira, R.P., Tanus-Santos, J.E., Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. Free Radic. Biol. Med. 51 (2011), 144–152.
156. Amaral, J.H., Ferreira, G.C., Pinheiro, L.C., Montenegro, M.F., Tanus-Santos, J.E., Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension. Redox Biol. 5 (2015), 340–346.
157. Kumar, D., Branch, B.G., Pattillo, C.B., Hood, J., Thoma, S., Simpson, S., Illum, S., Arora, N., Chidlow, J.H. Jr., Langston, W., Teng, X., Lefer, D.J., Patel, R.P., Kevil, C.G., Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 7540–7545.
158. Mitschke, M.M., Hoffmann, L.S., Gnad, T., Scholz, D., Kruithoff, K., Mayer, P., Haas, B., Sassmann, A., Pfeifer, A., Kilic, A., Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J. 27 (2013), 1621–1630.
159. Smorlesi, A., Frontini, A., Giordano, A., Cinti, S., The adipose organ: white-brown adipocyte plasticity and metabolic inflammation. Obes. Rev. 13:Suppl 2 (2012), 83–96.
160. Bordicchia, M., Liu, D., Amri, E.Z., Ailhaud, G., Dessi-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., Collins, S., Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122 (2012), 1022–1036.
161. Hara, Y., Wakino, S., Tanabe, Y., Saito, M., Tokuyama, H., Washida, N., Tatematsu, S., Yoshioka, K., Homma, K., Hasegawa, K., Minakuchi, H., Fujimura, K., Hosoya, K., Hayashi, K., Nakayama, K., Itoh, H., Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci. Signal., 4, 2011, ra3.
162. Jornayvaz, F.R., Shulman, G.I., Regulation of mitochondrial biogenesis. Essays Biochem. 47 (2010), 69–84.
163. Ogur, R., Coskun, O., Korkmaz, A., Oter, S., Yaren, H., Hasde, M., High nitrate intake impairs liver functions and morphology in rats; protective effects of alpha-tocopherol. Environ. Toxicol. Pharmacol. 20 (2005), 161–166.
164. Gatseva, P., Lazarova, A., Maximova, S., Pavlova, K., Experimental data on the effect of nitrates entering the organism with the drinking water. Folia Med. Plovdiv. 38 (1996), 75–83.
165. El-Wakf, A.M., Hassan, A., Elsaid, F.G., Elsaid, A., Hypothyroidism in male rats of different ages exposed to nitrate polluted drinking water. Res. J. Med. Med. Sci. 4 (2009), 160–164.
166. Chaoui, A.A., Zaki, A., Talibi, A., Chait, A., Derouiche, A., Aboussaouira, T., Benabdjlil, F., Himmi, T., Effects of inorganic nitrates on thyroid gland activity and morphology in female rats. Therapie 59 (2004), 471–475 [Abstract].
167. National Toxicology program, Toxicology and carcinogenesis studies of sodium nitrite (CAS NO. 7632-00-0) in F344/N rats and B6C3F1 mice (drinking water studies). Natl. Toxicol. Program Tech. Rep. Ser. 495 (2001), 7–273.
168. Chow, C.K., Chen, C.J., Gairola, C., Effect of nitrate and nitrite in drinking water on rats. Toxicol. Lett. 6 (1980), 199–206.
169. Ciji, A., Sahu, N.P., Pal, A.K., Akhtar, M.S., Nitrite-induced alterations in sex steroids and thyroid hormones of Labeo rohita juveniles: effects of dietary vitamin E and L-tryptophan. Fish Physiol. Biochem. 39 (2013), 1297–1307.
170. Zaki, A., Ait Chaoui, A., Talibi, A., Derouiche, A.F., Aboussaouira, T., Zarrouck, K., Chait, A., Himmi, T., Impact of nitrate intake in drinking water on the thyroid gland activity in male rat. Toxicol. Lett. 147 (2004), 27–33.
171. akasha, M., Kerban, A.A., Abobaker, S.a., Effect of nitrate on the body weight, food and water consumption and thyroid hormone in hybrid female rabbits. J. Veterinary Adv. 5 (2015), 912–918.
172. Ogur, R., Korkmaz, A., Hasde, M., Effects of high nitrate intake in rats. J. Basic Clin. Physiol. Pharmacol. 11 (2000), 47–56.
173. Bouaziz-Ketata, H., Salah, G.B., Salah, H.B., Marrekchi, R., Jamoussi, K., Boudawara, T., Fakhfekh, F., Zeghal, N., Nitrate-induced biochemical and histopathological changes in the liver of rats: ameliorative effect of Hyparrhenia hirta. Biomed. Environ. Sci. 27 (2014), 695–706.
174. Til, H.P., Kuper, C.F., Falke, H.E., Nitrite-induced adrenal effects in rats and the consequences for the no-observed-effect level. Food Chem. Toxicol. 35 (1997), 349–355.
175. Zanetti, M., Gortan Cappellari, G., Burekovic, I., Barazzoni, R., Stebel, M., Guarnieri, G., Caloric restriction improves endothelial dysfunction during vascular aging: effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. Exp. Gerontol. 45 (2010), 848–855.
176. Csiszar, A., Pacher, P., Kaley, G., Ungvari, Z., Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol. 3 (2005), 285–291.
177. Tanabe, T., Maeda, S., Miyauchi, T., Iemitsu, M., Takanashi, M., Irukayama-Tomobe, Y., Yokota, T., Ohmori, H., Matsuda, M., Exercise training improves ageing-induced decrease in eNOS expression of the aorta. Acta Physiol. Scand. 178 (2003), 3–10.
178. Matsushita, H., Chang, E., Glassford, A.J., Cooke, J.P., Chiu, C.P., Tsao, P.S., eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ. Res. 89 (2001), 793–798.
179. Smith, A.R., Visioli, F., Hagen, T.M., Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch. Biochem. Biophys. 454 (2006), 100–105.
180. Cernadas, M.R., Sanchez de Miguel, L., Garcia-Duran, M., Gonzalez-Fernandez, F., Millas, I., Monton, M., Rodrigo, J., Rico, L., Fernandez, P., de Frutos, T., Rodriguez-Feo, J.A., Guerra, J., Caramelo, C., Casado, S., Lopez, F., Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. 83 (1998), 279–286.
181. Patruno, A., Speranza, L., Tete, S., Mastrangelo, F., De Lutiis, M.A., Pesce, M., Franceschelli, S., Vinciguerra, I., Felaco, M., Grilli, A., iNOS activity in the aged rat liver tissue. J. Biol. Regul. Homeost. Agents 21 (2007), 89–95.
182. Goettsch, W., Lattmann, T., Amann, K., Szibor, M., Morawietz, H., Munter, K., Muller, S.P., Shaw, S., Barton, M., Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem. Biophys. Res. Commun. 280 (2001), 908–913.
183. Hezel, M.P., Liu, M., Schiffer, T.A., Larsen, F.J., Checa, A., Wheelock, C.E., Carlstrom, M., Lundberg, J.O., Weitzberg, E., Effects of long-term dietary nitrate supplementation in mice. Redox Biol. 5 (2015), 234–242.
184. Carlstrom, M., Larsen, F.J., Nystrom, T., Hezel, M., Borniquel, S., Weitzberg, E., Lundberg, J.O., Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 17716–17720.
185. Park, S.K., Tucker, K.L., O'Neill, M.S., Sparrow, D., Vokonas, P.S., Hu, H., Schwartz, J., Fruit, vegetable, and fish consumption and heart rate variability: the veterans administration normative aging study. Am. J. Clin. Nutr. 89 (2009), 778–786.
186. Bazzano, L.A., Li, T.Y., Joshipura, K.J., Hu, F.B., Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 31 (2008), 1311–1317.
187. Rammos, C., Hendgen-Cotta, U.B., Pohl, J., Totzeck, M., Luedike, P., Schulze, V.T., Kelm, M., Rassaf, T., Modulation of circulating macrophage migration inhibitory factor in the elderly. BioMed. Res. Int., 2014, 2014, 582586.
188. Jajja, A., Sutyarjoko, A., Lara, J., Rennie, K., Brandt, K., Qadir, O., Siervo, M., Beetroot supplementation lowers daily systolic blood pressure in older, overweight subjects. Nutr. Res. 34 (2014), 868–875.
189. Lara, J., Ogbonmwan, I., Oggioni, C., Zheng, D., Qadir, O., Ashor, A., Brandt, K., Mathers, J.C., Siervo, M., Effects of handgrip exercise or inorganic nitrate supplementation on 24-h ambulatory blood pressure and peripheral arterial function in overweight and obese middle age and older adults: a pilot RCT. Maturitas 82 (2015), 228–235.
190. Lyons, D., Roy, S., Patel, M., Benjamin, N., Swift, C.G., Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin. Sci. (Lond.) 93 (1997), 519–525.
191. Siervo, M., Lara, J., Jajja, A., Sutyarjoko, A., Ashor, A.W., Brandt, K., Qadir, O., Mathers, J.C., Benjamin, N., Winyard, P.G., Anning, C., Shore, A., Gilchrist, M., Ageing modifies the effects of beetroot juice supplementation on 24-hour blood pressure variability: an individual participant meta-analysis. Nitric Oxide 47 (2015), 97–105.
192. Tsai, F., Coyle, W.J., The microbiome and obesity: is obesity linked to our gut flora?. Curr. Gastroenterol. Rep. 11 (2009), 307–313.
193. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449 (2007), 804–810.
194. Million, M., Lagier, J.C., Yahav, D., Paul, M., Gut bacterial microbiota and obesity. Clin. Microbiol. Infect. 19 (2013), 305–313.
195. Koch, C.D., Gladwin, M.T., Freeman, B.A., Lundberg, J.O., Weitzberg, E., Morris, A., Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health. Free Radic. Biol. Med. 105 (2016), 48–67.
196. Gladwin, M.T., Haldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion. J. Clin. Invest. 113 (2004), 19–21.
197. McIlvenna, L.C., Monaghan, C., Liddle, L., Fernandez, B.O., Feelisch, M., Muggeridge, D.J., Easton, C., Beetroot juice versus chard gel: a pharmacokinetic and pharmacodynamic comparison of nitrate bioavailability. Nitric Oxide 66 (2017), 61–67.
198. Bryan, N.S., Tribble, G., Angelov, N., Oral microbiome and nitric oxide: the missing link in the management of blood pressure. Curr. Hypertens. Rep., 19, 2017, 33.
199. Korpela, K., Flint, H.J., Johnstone, A.M., Lappi, J., Poutanen, K., Dewulf, E., Delzenne, N., de Vos, W.M., Salonen, A., Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One, 9, 2014, e90702.
200. Tilg, H., Moschen, A.R., Microbiota and diabetes: an evolving relationship. Gut 63 (2014), 1513–1521.
201. Tuohy, K.M., Fava, F., Viola, R., ‘The way to a man's heart is through his gut microbiota’–dietary pro- and prebiotics for the management of cardiovascular risk. Proc. Nutr. Soc. 73 (2014), 172–185.
202. Kapil, V., Haydar, S.M., Pearl, V., Lundberg, J.O., Weitzberg, E., Ahluwalia, A., Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic. Biol. Med. 55 (2013), 93–100.
203. Hobbs, D.A., George, T.W., Lovegrove, J.A., The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies. Nutr. Res. Rev. 26 (2013), 210–222.
204. Petersson, J., Carlstrom, M., Schreiber, O., Phillipson, M., Christoffersson, G., Jagare, A., Roos, S., Jansson, E.A., Persson, A.E., Lundberg, J.O., Holm, L., Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic. Biol. Med. 46 (2009), 1068–1075.
205. Backhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 979–984.
206. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., Gordon, J.I., The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15718–15723.
207. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
208. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 11070–11075.
209. Tai, N., Wong, F.S., Wen, L., The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev. Endocr. Metab. Disord. 16 (2015), 55–65.
210. Henning, S.M., Yang, J., Shao, P., Lee, R.P., Huang, J., Ly, A., Hsu, M., Lu, Q.Y., Thames, G., Heber, D., Li, Z., Health benefit of vegetable/fruit juice-based diet: role of microbiome. Sci. Rep., 7, 2017, 2167.
211. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best. Pract. Res. Clin. Gastroenterol. 27 (2013), 73–83.
212. Tannenbaum, S.R., Correa, P., Nitrate and gastric cancer risks. Nature 317 (1985), 675–676.
213. Ward, M.H., Kilfoy, B.A., Weyer, P.J., Anderson, K.E., Folsom, A.R., Cerhan, J.R., Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 21 (2010), 389–395.
214. Santarelli, R.L., Pierre, F., Corpet, D.E., Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer 60 (2008), 131–144.
215. Jackson, J., Patterson, A.J., MacDonald-Wicks, L., McEvoy, M., The role of inorganic nitrate and nitrite in CVD. Nutr. Res. Rev., 2017, 1–18.
216. Bryan, N.S., Alexander, D.D., Coughlin, J.R., Milkowski, A.L., Boffetta, P., Ingested nitrate and nitrite and stomach cancer risk: an updated review. Food Chem. Toxicol. 50 (2012), 3646–3665.
217. Combet, E., El Mesmari, A., Preston, T., Crozier, A., McColl, K.E., Dietary phenolic acids and ascorbic acid: influence on acid-catalyzed nitrosative chemistry in the presence and absence of lipids. Free Radic. Biol. Med. 48 (2010), 763–771.
218. Kobayashi, J., Ohtake, K., Uchida, H., NO-Rich diet for lifestyle-related diseases. Nutrients 7 (2015), 4911–4937.
219. Alexander, D.D., Miller, A.J., Cushing, C.A., Lowe, K.A., Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies. Eur. J. Cancer Prev. 19 (2010), 328–341.
220. Lundberg, J.O., Gladwin, M.T., Weitzberg, E., Strategies to increase nitric oxide signalling in cardiovascular disease. Nat. Rev. Drug Discov. 14 (2015), 623–641.
221. Wallace, J.L., Ignarro, L.J., Fiorucci, S., Potential cardioprotective actions of no-releasing aspirin. Nat. Rev. Drug Discov. 1 (2002), 375–382.